Oral Menopause Hormone Therapy Linked to Increased Risk of N

The presence of NAFLD increased from 25.3% to 29.4% among patients receiving oral menopause hormone therapy.

Related Keywords

United States , American , Keun Kim , Sungkyunkwan University School Of Medicine , Menopause Clinic In Samsung Medical Center , American Menopause Society , Sung Eun Kim , Sungkyunkwan University School , Menopause Clinic , Samsung Medical Center , American Menopause , Hormone Therapy , Menopause Symptoms , Accessed September , Nafld , Nonalcoholic Fatty Liver Disease , Menopause Hormone Therapy , Lmht , Coral , Transdermal ,